Mandate

Vinge advises D. Carnegie & Co in connection with Blackstone’s mandatory offer

October 27, 2016

Vinge has advised D. Carnegie & Co AB (publ) (“D. Carnegie & Co”) in connection with a mandatory offer to the shareholders and warrant holders of D. Carnegie & Co, made by Blackstone through Vega Holdco S.à r.l. (”Vega Holdco”). Vega Holdco offers SEK 100 in cash per A- and B-share in D. Carnegie & Co. Based on all outstanding shares and warrants in the company, the total value of D. Carnegie & Co amounts to approximately SEK 7.8 billion.

Vinge’s team primarily consisted of Jesper Schönbeck, David Andersson and Sofie Bjärtun.

Related

Vinge has advised Verisure in connection with its IPO on Nasdaq Stockholm

Vinge has advised Verisure plc (“Verisure”) in connection with its IPO on Nasdaq Stockholm. Following the publication of the prospectus on 29 September 2025, trading in Verisure’s shares commenced today, 8 October 2025.
October 08, 2025

Vinge has advised Egetis Therapeutics in connection with a directed share issue

Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), listed on Nasdaq Stockholm, in connection with a directed share issue whereby Egetis Therapeutics raised proceeds of approximately SEK 183 million before transaction costs.
October 06, 2025

Vinge worked with funds advised by Agilitas on the buy-out of Vivicta (previously Tietoevry Tech Services), including on the issuance of senior secured bonds and on entering into a super senior RCF

Vinge, together with O’Melveny as lead counsel and Avance, worked with funds advised by Agilitas Private Equity LLP (“Agilitas”), the pan-European mid-market private equity firm, in their backing of Vivicta. The buy-out was previously announced on 24 March 2025 and closed on 2 September 2025.
October 03, 2025